BRCA2 and melanoma: We have found that LOXL3 binds to proteins that protect genome integrity (BRCA2, MSH2, SMC1A, NUMA1) and that its absence promotes a defective DNA damage checkpoint activation, deficient DNA repair and aberrant mitosis in melanoma cells.